Oral phenylpropanolamine is a common ingredient in many medications such as decongestants, cough remedies and weight control agents. There are numerous case reports in the literature suggesting that ...

Phenylpropanolamine is commonly found in appetite suppressants and cough or cold remedies. Case reports have linked the use of products containing phenylpropanolamine to hemorrhagic stroke, often ...

Kernan WN, Viscoli CM, Brass LM, Broderick JP, Brott T, Feldmann E, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000;343(25):1826-32. Background: Phenylpropanolamine ...

Learn everything you need to know about Chlorpheniramine and Phenylpropanolamine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side ...

Review the side-effects of Chlorpheniramine and Phenylpropanolamine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the ...

For decades, the sympathomimetic phenylpropanolamine (PPA; ±-norepinephrine) was an active ingredient found in popular children's over-the-counter (OTC) cold, cough, and allergy medications. To ...

Data Bridge Market Research has recently published a research report titled Global Phenylpropanolamine (PPA) Market Growth 2021-2028 that comprises of productive information of the market. The report ...

The most common side effects of phenylpropanolamine (PPA) are hypertension and headache. In combination with caffeine, ephedrine, or an antihistamine, PPA can cause sustained tachycardia. Its ...

Phenylpropanolamine, a main ingredient in almost all the formulations available in the market as prescription and OTC for the cold related indications as well as for weight lose, has been proved to be ...

To the Editor: The request by the Food and Drug Administration (FDA) for the voluntary withdrawal of all products containing phenylpropanolamine on the basis of the data of Kernan et al. (Dec. 21 ...

FDA issues public health warning on phenylpropanolamine. FDA Talk Paper T00-58; 6 Nov 2000. Available: www.fda.gov/bbs/topics/ANSWERS/ANS01051.html (accessed 5 Feb 2001).

Claim: Drug products containing PPA (phenylpropanolamine) were pulled from the market due to FDA concerns over a possible connection to strokes. All drugs containing PHENYLPROPANOLAMINE (PPA) are ...